HTA334 Assessment of Vaccines in Europe, the HPV Example: Can the EU Joint Clinical HTA Regulation Result in More Consistent Vaccine Evaluations and Improve Access Across EU Countries?
Abstract
Authors
F. Kakanou
F. Kakanou
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now